2010 Q2/Global Life Sciences
INDEX Facts
- Completed date:
21 Jun 2010
- Total URLs tested:
35,708
- Total tests run:
11,698,492
- Total number of PDF's:
3,592
- URLs failing functional tests:
2.11%
- Pages failing code standards:
84.63%
- Pages missing a title:
4.86%
- Pages failing accessibility level A:
48.74%
- Pages failing accessibility level AA:
97.83%
- Poorest code quality:
Helsinn Healthcare S.A. (http://www.helsinn.com/) - 21,058 failures
- Fastest average response time:
Newron (http://www.newron.com/)
Accessibility and Performance rankings
This table reports the average response time we recorded when testing each site. A response time above 0.7 seconds can have a negative effect on user experience.
This table reports the percentage of pages on the sites we tested that passed automated WCAG 1.0 A and AA testing (0 means every page had an issue).
| Organisation | Avg. Response | Download (kB/s) |
|---|---|---|
| Only available for Qtr 4 2010 onwards | ||
| Organisation | A | AA |
|---|---|---|
| F. Hoffmann-La Roche AG Switzerland | 100.00 | 43.20 |
| Antares Pharma AG | 100.00 | 12.00 |
| Lunamed AG | 100.00 | 8.33 |
| Basilea Pharmaceutica Ltd. | 100.00 | 7.20 |
| Arpida AG | 100.00 | 0.80 |
| Evolva SA | 100.00 | 0.80 |
| BioPartners GmbH | 100.00 | 0.00 |
| BioVersys GmbH | 100.00 | 0.00 |
| Covagen AG | 100.00 | 0.00 |
| Galenica Ltd. | 100.00 | 0.00 |
| Johnson & Johnson Pharmaceutical Research & Development | 100.00 | 0.00 |
| Kuros Biosurgery AG | 100.00 | 0.00 |
| Neurimmune Therapeutics AG | 100.00 | 0.00 |
| Nycomed International Management GmbH | 100.00 | 0.00 |
| OMIDA AG | 100.00 | 0.00 |
| Tricom GmbH, Pharma Division | 100.00 | 0.00 |
| Valeant Pharmaceuticals Switzerland GmbH | 100.00 | 0.00 |
| AmVac AG | 99.20 | 0.00 |
| Ferring International Center SA | 99.20 | 0.00 |
| Medinova AG | 99.20 | 0.00 |
| Addex Pharmaceuticals | 98.40 | 0.00 |
| Cytos Biotechnology AG | 98.40 | 0.00 |
| Siegfried AG | 98.40 | 0.00 |
| Biogen Idec International GmbH | 98.33 | 0.00 |
| Newron | 97.89 | 0.00 |
| F. Hoffmann-La Roche AG Global | 97.60 | 24.00 |
| Helvepharm AG | 96.80 | 0.00 |
| Axenoll AG | 94.81 | 0.00 |
| 4-Antibody AG | 94.74 | 0.00 |
| Lipideon Biotechnology AG | 90.00 | 0.00 |
| CSL Behring AG | 87.50 | 0.00 |
| Neurotune | 85.71 | 0.00 |
| Novartis International AG | 84.80 | 0.00 |
| Crucell | Berna Biotech Ltd | 73.33 | 0.00 |
| Med Discovery S.A. | 65.60 | 0.00 |
| Axentis Pharma AG | 63.64 | 0.00 |
| Nycomed Pharma AG | 60.00 | 0.00 |
| Streuli Pharma AG | 56.80 | 0.00 |
| Medipol SA | 45.24 | 30.95 |
| Anavex Life Sciences Corp. | 32.35 | 21.57 |
| Baxter Switzerland | 32.00 | 0.00 |
| Merck Serono International SA | 31.20 | 0.00 |
| Octapharma AG | 31.20 | 0.00 |
| NovImmune | 28.00 | 0.00 |
| Aurora Pharma GmbH | 23.91 | 0.00 |
| Max Zeller Söhne AG | 22.40 | 0.00 |
| Bayer Schweiz AG | 20.00 | 0.00 |
| Spirig Pharma AG | 10.40 | 0.00 |
| Solvay Pharma AG | 8.70 | 0.00 |
| AC Immune SA | 7.89 | 0.00 |
| Merck Sharp & Dohme-Chibret AG | 7.63 | 0.00 |
| PharmaSwiss SA - HQ | 7.14 | 0.00 |
| Actelion Ltd. | 4.80 | 0.00 |
| Novartis Pharma Schweiz AG | 4.80 | 0.00 |
| AstraZeneca AG | 3.20 | 0.00 |
| Helsinn Healthcare S.A. | 3.08 | 0.00 |
| Mepha Pharma AG | 2.40 | 0.00 |
| Cryo-Save AG | 2.15 | 0.00 |
| Permamed AG | 1.60 | 0.00 |
| Debiopharm S.A. | 0.80 | 0.80 |
| Schwabe Pharma AG | 0.80 | 0.00 |
| 3-V Biosciences GmbH | 0.00 | 0.00 |
| Alpex Pharma SA | 0.00 | 0.00 |
| ArisGen SA | 0.00 | 0.00 |
| Auris Medical AG | 0.00 | 0.00 |
| ESBATECH AG | 0.00 | 0.00 |
| Ergonex Pharma GmbH | 0.00 | 0.00 |
| GKL Biotec AG | 0.00 | 0.00 |
| GeNeuro SA | 0.00 | 0.00 |
| GenKyoTex SA | 0.00 | 0.00 |
| GlycoVaxyn AG | 0.00 | 0.00 |
| Gruenenthal Pharma AG | 0.00 | 0.00 |
| Kenta Biotech AG | 0.00 | 0.00 |
| Molecular Partners AG | 0.00 | 0.00 |
| Neurim Pharmaceuticals S.A. | 0.00 | 0.00 |
| Nitec Pharma AG | 0.00 | 0.00 |
| Novo Nordisk Pharma AG | 0.00 | 0.00 |
| OM PHARMA | 0.00 | 0.00 |
| Vifor (International) Ltd. | 0.00 | 0.00 |
| mondoBIOTECH AG | 0.00 | 0.00 |
Error free sites
The following sites scored full marks for Function.
- Alpex Pharma SA
- Antares Pharma AG
- ArisGen SA
- Johnson & Johnson Pharmaceutical Research & Development
- Kuros Biosurgery AG
- Lipideon Biotechnology AG
- Lunamed AG
- Med Discovery S.A.
- Medinova AG
- Molecular Partners AG
- Neurimmune Therapeutics AG
- Newron
- Nycomed International Management GmbH
- PharmaSwiss SA - HQ
- Tricom GmbH, Pharma Division
Failing A & AA on every page
The following sites failed high priority tests on every page.
- 3-V Biosciences GmbH
- Alpex Pharma SA
- ArisGen SA
- Auris Medical AG
- Ergonex Pharma GmbH
- ESBATECH AG
- GeNeuro SA
- GenKyoTex SA
- GKL Biotec AG
- GlycoVaxyn AG
- Gruenenthal Pharma AG
- Kenta Biotech AG
- Molecular Partners AG
- mondoBIOTECH AG
- Neurim Pharmaceuticals S.A.
- Nitec Pharma AG
- Novo Nordisk Pharma AG
- OM PHARMA
- Vifor (International) Ltd.
Excluded from INDEX
The following sites were excluded from the INDEX.
- Anergis SA
- Dybly AG
- IBSA
- Janssen-Cilag AG
- Eli Lilly Schweiz AG
- Lumavita AG
- Pfizer AG
- Wyeth Pharmaceuticals AG
PDF testing
24.3% of checked PDFs were not tagged for accessibility.
Sitemorse performs twenty eight checks on PDF documents as part of our website benchmarking to ensure users do not experience problems such as broken links, or failing email addresses - we are also the first to test the accessibility compliance of PDF's.
Top ten functional failures
The most common categories of functional failure.
| url/fetch/notfound File not found |
76.73% |
| url/fetch/noaddr Host not found in DNS |
8.38% |
| url/fetch/badscheme URL scheme was unrecognised |
4.79% |
| url/fetch/noeoh No end-of-headers found in HTTP response |
3.19% |
| url/fetch/unknownstatus Unknown status code received from web server |
2.13% |
| url/fetch/timeout Timeout downloading file |
1.73% |
| url/fetch/accessdenied Access is denied |
1.46% |
| url/fetch/badcookie Web server attempted to set invalid cookie |
0.93% |
| url/fetch/exception Exception while downloading file |
0.40% |
| url/fetch/redirectloop Redirect points back to the original page |
0.13% |
Top ten code quality failures
The most common categories of code quality failure.
| file/html/missingclose An element is missing the required close tag |
29.16% |
| file/html/tagnotallowed A start tag has been found in a position in which that element may not appear |
17.27% |
| file/html/badentity Invalid character in entity |
13.53% |
| file/html/unknownentity Unknown entity name |
13.19% |
| file/html/badvalue Invalid attribute value |
7.36% |
| file/html/badattr Invalid attribute name |
5.18% |
| file/html/closingunopened A redundant close tag was found |
4.37% |
| file/html/unknowntag A start or end tag was found which was unrecognised |
3.79% |
| file/html/missingattr A start tag is missing required attributes |
1.90% |
| url/fetch/moved A "301 Moved Permanently" response was received |
0.77% |